Short Interest in United-Guardian, Inc. (NASDAQ:UG) Decreases By 33.3%

United-Guardian, Inc. (NASDAQ:UG) was the recipient of a significant drop in short interest during the month of April. As of April 15th, there was short interest totalling 1,200 shares, a drop of 33.3% from the March 31st total of 1,800 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 8,500 shares, the short-interest ratio is presently 0.1 days.

United-Guardian Price Performance

Shares of NASDAQ:UG opened at $8.26 on Friday. United-Guardian has a 1 year low of $5.79 and a 1 year high of $10.23. The firm has a market capitalization of $37.91 million, a PE ratio of 14.75 and a beta of 0.73. The business’s 50 day moving average price is $7.96 and its 200-day moving average price is $7.71.

United-Guardian (NASDAQ:UG) last announced its quarterly earnings data on Friday, March 22nd. The company reported $0.16 earnings per share for the quarter. United-Guardian had a return on equity of 24.26% and a net margin of 23.71%. The company had revenue of $2.61 million for the quarter.

United-Guardian Announces Dividend

The firm also recently disclosed a Semi-Annual dividend, which was paid on Tuesday, February 20th. Shareholders of record on Monday, February 12th were issued a $0.10 dividend. The ex-dividend date was Friday, February 9th. This represents a yield of 5.8%. United-Guardian’s payout ratio is 89.29%.

Institutional Investors Weigh In On United-Guardian

An institutional investor recently raised its position in United-Guardian stock. Gamco Investors INC. ET AL lifted its holdings in shares of United-Guardian, Inc. (NASDAQ:UG) by 4.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 154,500 shares of the company’s stock after purchasing an additional 7,000 shares during the quarter. Gamco Investors INC. ET AL owned about 3.37% of United-Guardian worth $1,163,000 as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 23.16% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on shares of United-Guardian in a report on Saturday, April 20th. They set a “buy” rating on the stock.

About United-Guardian

United-Guardian, Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally The company offers cosmetic ingredients, including LUBRAJEL, a line of water-based gel formulation for sensory enhancement, lubrication, and texture to personal care products; LUBRAJEL NATURAL for skin moisturizing; LUBRAJEL MARINE that develops natural products using naturally derived polymers; LUBRAJEL OlL NATURAL, which makes luxuriant textures without adding viscosity; LUBRAJEL TERRA, a multifunctional, moisturizing hydrogel products; LUBRASIL II SB, a formulation of LUBRAJEL; LUBRAJEL II XD; B-122, a powdered lubricant used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; and ORCHID COMPLEX, an oil-soluble base for extract of fresh orchids used in fragrance products, such as perfumes and toiletries.